{"id":4239,"date":"2024-08-19T14:45:37","date_gmt":"2024-08-19T14:45:37","guid":{"rendered":"https:\/\/www.everpharma.com\/?p=4239"},"modified":"2024-08-20T05:11:48","modified_gmt":"2024-08-20T05:11:48","slug":"ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate","status":"publish","type":"post","link":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/","title":{"rendered":"EVER Pharma erh\u00e4lt EU-Zulassung f\u00fcr Testosteronenantate"},"content":{"rendered":"\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.67%\">\n<p><strong>EVER Pharma, ein vollintegrierter Pharmaspezialist, hat die Zulassung von Testosteronenantate in der Europ\u00e4ischen Union f\u00fcr die Behandlung des m\u00e4nnlichen Hypogonadismus bekannt gegeben. Diese Erkrankung, die durch unzureichende Testosteronproduktion gekennzeichnet ist, betrifft weltweit bis zu 10% der M\u00e4nner und 40% der M\u00e4nner im Alter von 45 Jahren<sup>1<\/sup>.<\/strong><\/p>\n\n\n\n<p>M\u00e4nnlicher Hypogonadismus kann die Lebensqualit\u00e4t erheblich beeintr\u00e4chtigen und sich durch Symptome wie reduzierte Muskelmasse, M\u00fcdigkeit und geringes sexuelles Verlangen \u00e4u\u00dfern. Testosteronenantat ist ein langwirkendes injizierbares Testosteron, das nachweislich diese Symptome wirksam lindert und das allgemeine Wohlbefinden der Patienten verbessert<sup>2<\/sup>.<\/p>\n\n\n\n<p>&#8222;M\u00e4nnlicher Hypogonadismus hat erhebliche Auswirkungen auf die Lebensqualit\u00e4t, daher ist eine wirksame Therapie von entscheidender Bedeutung. Wir sind froh, diese Therapie anbieten zu k\u00f6nnen und den Zugang f\u00fcr Patienten zu verbessern,\u201d sagte Georges Kahwati, General Manager bei EVER Pharma.<\/p>\n\n\n\n<p>Die Zulassung von Testosteronenantat unterstreicht die Expertise von EVER Pharma in der Entwicklung und Herstellung von Hormontherapien. Sie best\u00e4tigt zudem das Engagement des Unternehmens, essenzielle Arzneimittel f\u00fcr Patienten weltweit bereitzustellen. Eine globale Markteinf\u00fchrung ist geplant.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/08\/TEN-PR-Image-1024x1024.png\" alt=\"\" class=\"wp-image-4234\" style=\"width:413px;height:auto\" srcset=\"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/08\/TEN-PR-Image-1024x1024.png 1024w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/08\/TEN-PR-Image-300x300.png 300w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/08\/TEN-PR-Image-150x150.png 150w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/08\/TEN-PR-Image-768x768.png 768w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/08\/TEN-PR-Image-1536x1536.png 1536w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/08\/TEN-PR-Image-2048x2048.png 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:63px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-wpco-accordion accordion\" id=\"accordion-4239-1\">\n<div class=\"wp-block-wpco-accordion-body accordion-item\"><div class=\"accordion-header\" id=\"accordion-4239-1-item-1-heading\"><button class=\"accordion-button has-theme-gray-background-color has-theme-copy-color\" data-bs-toggle=\"collapse\" data-bs-target=\"#accordion-4239-1-item-1-body\">Sources<\/button><\/div><div class=\"accordion-collapse collapse\" id=\"accordion-4239-1-item-1-body\" aria-labelledby=\"accordion-4239-1-item-1-heading\" data-bs-parent=\"#accordion-4239-1\"><div class=\"accordion-body has-theme-light-gray-background-color has-theme-copy-color\">\n<p><sup>1<\/sup>Campbell K., Muthigi A., Ghomeshi A., Schuppe K., Sandler M. D., &amp; Ramasamy R. (2023). Safety Aspects and Rational Use of Testosterone Undecanoate in the Treatment of Testosterone Deficiency: Clinical Insights. Drug Healthc Patient Safety, 15, 73-84.<br><sup>2<\/sup>Berlseth K. E., Thirumalai A., Amory J. K. (2016). Pharmacologic Therapy in Men&#8217;s Health: Hypogonadism, Erectile Dysfunction, and Benign Prostatic Hyperplasia. Medical Clinics of North America, 100(4), 791-805.<\/p>\n\n\n\n<p><\/p>\n<\/div><\/div><\/div>\n<\/div>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>EVER Pharma, ein vollintegrierter Pharmaspezialist, hat die Zulassung von Testosteronenantate in der Europ\u00e4ischen Union f\u00fcr die Behandlung des m\u00e4nnlichen Hypogonadismus bekannt gegeben. Diese Erkrankung, die durch unzureichende Testosteronproduktion gekennzeichnet ist, betrifft weltweit bis zu 10% der M\u00e4nner und 40% der M\u00e4nner im Alter von 45 Jahren1. M\u00e4nnlicher Hypogonadismus kann die Lebensqualit\u00e4t erheblich beeintr\u00e4chtigen und sich &hellip; <a href=\"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/\">Weiterlesen<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-4239","post","type-post","status-publish","format-standard","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EVER Pharma erh\u00e4lt EU-Zulassung f\u00fcr Testosteronenantate - EVER Pharma<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EVER Pharma erh\u00e4lt EU-Zulassung f\u00fcr Testosteronenantate - EVER Pharma\" \/>\n<meta property=\"og:description\" content=\"EVER Pharma, ein vollintegrierter Pharmaspezialist, hat die Zulassung von Testosteronenantate in der Europ\u00e4ischen Union f\u00fcr die Behandlung des m\u00e4nnlichen Hypogonadismus bekannt gegeben. Diese Erkrankung, die durch unzureichende Testosteronproduktion gekennzeichnet ist, betrifft weltweit bis zu 10% der M\u00e4nner und 40% der M\u00e4nner im Alter von 45 Jahren1. M\u00e4nnlicher Hypogonadismus kann die Lebensqualit\u00e4t erheblich beeintr\u00e4chtigen und sich &hellip; Weiterlesen\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/\" \/>\n<meta property=\"og:site_name\" content=\"EVER Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-19T14:45:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-20T05:11:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/08\/TEN-PR-Image-1024x1024.png\" \/>\n<meta name=\"author\" content=\"Magdalena\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Magdalena\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\\\/\"},\"author\":{\"name\":\"Magdalena\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#\\\/schema\\\/person\\\/fddfefac0cbd5adf0a20c4e09a52cd65\"},\"headline\":\"EVER Pharma erh\u00e4lt EU-Zulassung f\u00fcr Testosteronenantate\",\"datePublished\":\"2024-08-19T14:45:37+00:00\",\"dateModified\":\"2024-08-20T05:11:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\\\/\"},\"wordCount\":244,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/TEN-PR-Image-1024x1024.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\\\/\",\"url\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\\\/\",\"name\":\"EVER Pharma erh\u00e4lt EU-Zulassung f\u00fcr Testosteronenantate - EVER Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/TEN-PR-Image-1024x1024.png\",\"datePublished\":\"2024-08-19T14:45:37+00:00\",\"dateModified\":\"2024-08-20T05:11:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/TEN-PR-Image-1024x1024.png\",\"contentUrl\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/TEN-PR-Image-1024x1024.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/news\\\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EVER Pharma erh\u00e4lt EU-Zulassung f\u00fcr Testosteronenantate\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/\",\"name\":\"EVER Pharma\",\"description\":\"Dedicated to health.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":[\"Organization\",\"MedicalOrganization\"],\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#organization\",\"name\":\"EVER Pharma\",\"url\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/ever-pharma-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/ever-pharma-logo.png\",\"width\":240,\"height\":67,\"caption\":\"EVER Pharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"legalName\":\"EVER Neuro Pharma GmbH\",\"foundingDate\":\"1934-01-01\",\"description\":\"EVER Pharma is a fully integrated specialty pharmaceuticals company specializing in the research, development, and production of sterile injectables and specialty generics for neurology, oncology, intensive care, and hormone therapeutics worldwide.\",\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"Oberburgau 3\",\"addressLocality\":\"Unterach am Attersee\",\"addressRegion\":\"Ober\u00f6sterreich\",\"postalCode\":\"4866\",\"addressCountry\":\"AT\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"contactType\":\"customer service\",\"telephone\":\"+43 7665 20555 0\",\"email\":\"office@everpharma.com\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ever-pharma\\\/\",\"https:\\\/\\\/www.wikidata.org\\\/wiki\\\/Q30268961\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#\\\/schema\\\/person\\\/fddfefac0cbd5adf0a20c4e09a52cd65\",\"name\":\"Magdalena\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e81cd7fba1e19c19fca1ea100bdf2dc3d182f19e790ce2afa3446fd8017b4fd0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e81cd7fba1e19c19fca1ea100bdf2dc3d182f19e790ce2afa3446fd8017b4fd0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e81cd7fba1e19c19fca1ea100bdf2dc3d182f19e790ce2afa3446fd8017b4fd0?s=96&d=mm&r=g\",\"caption\":\"Magdalena\"},\"sameAs\":[\"https:\\\/\\\/everpharma.com\"],\"url\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/author\\\/mschmitzberger\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EVER Pharma erh\u00e4lt EU-Zulassung f\u00fcr Testosteronenantate - EVER Pharma","robots":{"index":"noindex","follow":"follow"},"og_locale":"de_DE","og_type":"article","og_title":"EVER Pharma erh\u00e4lt EU-Zulassung f\u00fcr Testosteronenantate - EVER Pharma","og_description":"EVER Pharma, ein vollintegrierter Pharmaspezialist, hat die Zulassung von Testosteronenantate in der Europ\u00e4ischen Union f\u00fcr die Behandlung des m\u00e4nnlichen Hypogonadismus bekannt gegeben. Diese Erkrankung, die durch unzureichende Testosteronproduktion gekennzeichnet ist, betrifft weltweit bis zu 10% der M\u00e4nner und 40% der M\u00e4nner im Alter von 45 Jahren1. M\u00e4nnlicher Hypogonadismus kann die Lebensqualit\u00e4t erheblich beeintr\u00e4chtigen und sich &hellip; Weiterlesen","og_url":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/","og_site_name":"EVER Pharma","article_published_time":"2024-08-19T14:45:37+00:00","article_modified_time":"2024-08-20T05:11:48+00:00","og_image":[{"url":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/08\/TEN-PR-Image-1024x1024.png","type":"","width":"","height":""}],"author":"Magdalena","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"Magdalena","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/#article","isPartOf":{"@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/"},"author":{"name":"Magdalena","@id":"https:\/\/www.everpharma.com\/de\/#\/schema\/person\/fddfefac0cbd5adf0a20c4e09a52cd65"},"headline":"EVER Pharma erh\u00e4lt EU-Zulassung f\u00fcr Testosteronenantate","datePublished":"2024-08-19T14:45:37+00:00","dateModified":"2024-08-20T05:11:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/"},"wordCount":244,"commentCount":0,"publisher":{"@id":"https:\/\/www.everpharma.com\/de\/#organization"},"image":{"@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/#primaryimage"},"thumbnailUrl":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/08\/TEN-PR-Image-1024x1024.png","articleSection":["News"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/","url":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/","name":"EVER Pharma erh\u00e4lt EU-Zulassung f\u00fcr Testosteronenantate - EVER Pharma","isPartOf":{"@id":"https:\/\/www.everpharma.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/#primaryimage"},"image":{"@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/#primaryimage"},"thumbnailUrl":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/08\/TEN-PR-Image-1024x1024.png","datePublished":"2024-08-19T14:45:37+00:00","dateModified":"2024-08-20T05:11:48+00:00","breadcrumb":{"@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/#primaryimage","url":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/08\/TEN-PR-Image-1024x1024.png","contentUrl":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/08\/TEN-PR-Image-1024x1024.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.everpharma.com\/de\/"},{"@type":"ListItem","position":2,"name":"EVER Pharma erh\u00e4lt EU-Zulassung f\u00fcr Testosteronenantate"}]},{"@type":"WebSite","@id":"https:\/\/www.everpharma.com\/de\/#website","url":"https:\/\/www.everpharma.com\/de\/","name":"EVER Pharma","description":"Dedicated to health.","publisher":{"@id":"https:\/\/www.everpharma.com\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.everpharma.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":["Organization","MedicalOrganization"],"@id":"https:\/\/www.everpharma.com\/de\/#organization","name":"EVER Pharma","url":"https:\/\/www.everpharma.com\/de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.everpharma.com\/de\/#\/schema\/logo\/image\/","url":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2022\/07\/ever-pharma-logo.png","contentUrl":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2022\/07\/ever-pharma-logo.png","width":240,"height":67,"caption":"EVER Pharma"},"image":{"@id":"https:\/\/www.everpharma.com\/de\/#\/schema\/logo\/image\/"},"legalName":"EVER Neuro Pharma GmbH","foundingDate":"1934-01-01","description":"EVER Pharma is a fully integrated specialty pharmaceuticals company specializing in the research, development, and production of sterile injectables and specialty generics for neurology, oncology, intensive care, and hormone therapeutics worldwide.","address":{"@type":"PostalAddress","streetAddress":"Oberburgau 3","addressLocality":"Unterach am Attersee","addressRegion":"Ober\u00f6sterreich","postalCode":"4866","addressCountry":"AT"},"contactPoint":{"@type":"ContactPoint","contactType":"customer service","telephone":"+43 7665 20555 0","email":"office@everpharma.com"},"sameAs":["https:\/\/www.linkedin.com\/company\/ever-pharma\/","https:\/\/www.wikidata.org\/wiki\/Q30268961"]},{"@type":"Person","@id":"https:\/\/www.everpharma.com\/de\/#\/schema\/person\/fddfefac0cbd5adf0a20c4e09a52cd65","name":"Magdalena","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/e81cd7fba1e19c19fca1ea100bdf2dc3d182f19e790ce2afa3446fd8017b4fd0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e81cd7fba1e19c19fca1ea100bdf2dc3d182f19e790ce2afa3446fd8017b4fd0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e81cd7fba1e19c19fca1ea100bdf2dc3d182f19e790ce2afa3446fd8017b4fd0?s=96&d=mm&r=g","caption":"Magdalena"},"sameAs":["https:\/\/everpharma.com"],"url":"https:\/\/www.everpharma.com\/de\/author\/mschmitzberger\/"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/posts\/4239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/comments?post=4239"}],"version-history":[{"count":7,"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/posts\/4239\/revisions"}],"predecessor-version":[{"id":4248,"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/posts\/4239\/revisions\/4248"}],"wp:attachment":[{"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/media?parent=4239"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/categories?post=4239"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/tags?post=4239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}